(CRNC) Cerence - Ratings and Ratios
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US1567271093
CRNC: AI, Virtual, Assistants, Speech, Recognition, Software, Services
Cerence Inc. (NASDAQ: CRNC) specializes in AI-driven virtual assistant solutions tailored for the automotive and mobility industries, serving markets globally, including the United States, Europe, the Middle East, Africa, and Asia-Pacific. The companys product portfolio includes edge software components, cloud-connected services, virtual assistant coexistence capabilities, and professional services. Its conversational AI solutions encompass speech recognition, natural language understanding, speech signal enhancement, text-to-speech, and acoustic modeling technology. Cerence was spun off from Nuance Communications in 2020 and is headquartered in Burlington, Massachusetts.
From a technical perspective, CRNC is currently trading at $11.61, below its 20-day SMA of $13.25 and 50-day SMA of $12.40, but above its 200-day SMA of $5.77. The stock faces resistance at $14.3 and $20.1, with support levels at $9.1, $7.4, and $3.1. The average 20-day volume is 3,053,750 shares, with an ATR of $1.92, indicating moderate volatility.
Fundamentally, Cerence has a market cap of $542.15 million, with a forward P/E of 243.90 and a P/B ratio of 4.50. The P/S ratio stands at 2.22, reflecting its revenue multiple. The companys RoE is currently not available due to insufficient data.
Additional Sources for CRNC Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
CRNC Stock Overview
| Market Cap in USD | 328m |
| Sector | Technology |
| Industry | Software - Application |
| GiC Sub-Industry | Systems Software |
| IPO / Inception | 2019-10-02 |
CRNC Stock Ratings
| Growth Rating | -40.3 |
| Fundamental | -13.4 |
| Dividend Rating | 0.0 |
| Rel. Strength | -2.66 |
| Analysts | 3.29/5 |
| Fair Price Momentum | 7.93 USD |
| Fair Price DCF | 9.80 USD |
CRNC Dividends
No Dividends PaidCRNC Growth Ratios
| Growth Correlation 3m | -90% |
| Growth Correlation 12m | 57.4% |
| Growth Correlation 5y | -85.8% |
| CAGR 5y | -14.36% |
| CAGR/Max DD 5y | -0.15 |
| Sharpe Ratio 12m | -0.83 |
| Alpha | -11.48 |
| Beta | 1.630 |
| Volatility | 123.54% |
| Current Volume | 1094.3k |
| Average Volume 20d | 1096.4k |
As of April 26, 2025, the stock is trading at USD 9.71 with a total of 1,094,333 shares traded.
Over the past week, the price has changed by +36.76%, over one month by -1.52%, over three months by -25.88% and over the past year by +3.41%.
Neither. Based on ValueRay Fundamental Analyses, Cerence is currently (April 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -13.41 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of CRNC as of April 2025 is 7.93. This means that CRNC is currently overvalued and has a potential downside of -18.33%.
Cerence has received a consensus analysts rating of 3.29. Therefor, it is recommend to hold CRNC.
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, CRNC Cerence will be worth about 8.8 in April 2026. The stock is currently trading at 9.71. This means that the stock has a potential downside of -9.47%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 11.6 | 19.3% |
| Analysts Target Price | 7.2 | -25.8% |
| ValueRay Target Price | 8.8 | -9.5% |